Published: Sun, March 19, 2017
World | By Lorena Waters

Cytomegalovirus - American Family Physician

Cytomegalovirus - American Family Physician

1. De Jong MD, Galasso GJ, Gazzard B, Griffiths PD, Jabs DA, Kern ER, Spector SA. Summary of the II International Symposium on Cytomegalovirus. Antiviral Res . 1998; 39: 141-62 ....

2. Bale JF Jr, Petheram SJ, Souza IE, Murph JR. Cytomegalovirus reinfection in young children. J Pediatr . 1996; 128: 347-52.

3. Adler SP. Cytomegalovirus and child day care. Evidence for an increased infection rate among day-care workers. N Engl J Med . 1989; 321: 1290-6.

4. Bale JF Jr, Zimmerman B, Dawson JD, Souza IE, Petheram SJ, Murph JR. Cytomegalovirus transmission in child care homes. Arch Pediatr Adolesc Med . 1999; 153: 75-9.

5. Balcarek KB, Bagley R, Cloud GA, RF Pass. Cytomegalovirus infection among employees of a children's hospital. No evidence for increased risk associated with patient care. JAMA . 1990; 263: 840-4.

6. Evans AS. Infectious mononucleosis and related syndromes. Am J Med Sci . 1978; 276: 325-39.

7. Klemola E, Kaariainen L. Cytomegalovirus as a possible cause of a disease resembling infectious mononucleosis. Br Med J . 1965; 5470: 1099-102.

8. Jordan MC, Rousseau W, Stewart JA, Noble GR, Chin TD. Spontaneous cytomegalovirus mononucleosis. Ann Intern Med . 1973; 79: 153-60.

9. Drago F, Aragone MG, Lugani C, Rebora A. Cytomegalovirus infection in normal and immunocompromised humans. A review. Dermatology . 2000; 200: 189-95.

10. Kano Y, Shiohara T. Current understanding of cytomegalovirus infection in immunocompetent individuals. Dermatol Sci . 2000; 22: 196-204.

11. Horwitz CA, Henle W, Henle G. Diagnostic aspects of the cytomegalovirus mononucleosis syndrome in previously healthy persons. Postgrad Med . 1979; 66: 153-8.

12. Wright JG. Severe thrombocytopenia secondary to asymptomatic cytomegalovirus infection in an immunocompetent host. J Clin Pathol . 1992; 45: 1037-8.

HIV & amp; AIDS Information :: Types of test - Confirmatory tests
For example, a test with the sensitivity of 99.8% will correctly identify 998 of every 1000 HIV-positive people who take it. The principle of this sequential testing strategy is that the first tests used should have very high sensitivity.

Maternal Defends Honest Mistake: A Kosher Today Exclusive - Kosher Today
Maternity expects the relabeling with the updated label to be successfully completed in the near future. " As requested by the FDA, a new label- with complete information in English- has been prepared.

YONDELIS® (trabectedin) for Healthcare Professionals
Embryofetal Toxicity - Based on its mechanism of action, YONDELIS can cause fetal harm when administered to a pregnant woman. Ten patients (2.6%) experienced neutropenic sepsis, 5 of whom had febrile neutropenia, which was fatal in 4 patients (1.1%).

14. Eddleston M, Peacock S, Juniper M, Warrell DA. Severe cytomegalovirus infection in immunocompetent patients. Clin Infect Dis . 1997; 24: 52-6.

15. Tsaparas YF, Brigden ML, Mathias R, Thomas E, Raboud J, Doyle P. Proportion positive for Epstein-Barr virus, cytomegalovirus, human herpesvirus 6, Toxoplasma, and human immunodeficiency virus types 1 and 2 in heterophile-negative patients with an absolute Lymphocytosis or an instrument-generated atypical lymphocyte flag. Arch Pathol Lab Med . 2000; 124: 1324-30.

16. Mattes FM, McLaughlin JE, Emery VC, Clark DA, Griffiths PD. Histopathological detection of owl's eye inclusions is still specific for cytomegalovirus in the era of human herpesviruses 6 and 7. J Clin Pathol . 2000; 53: 612-4.

17. Bolyard EA, Tablan OC, Williams WW, Pearson ML, Shapiro CN, Deitchmann SD. Guideline for infection control in healthcare personnel, 1998. Infect Control Hosp Epidemiol . 1998; 19: 407-63.

18. Hoover DR, Saah AJ, Bacellar H, Phair J, Detels R, Anderson R, et al. Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis. N Engl J Med . 1993; 329: 1922-6.

19. Deayton JR, Wilson P, Sabin CA, Davey CC, Johnson MA, Emery VC, et al. Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy. AIDS . 2000; 14: 1163-70.

20. Holland G, Tufail A, Jordon M. Cytomegalovirus diseases. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular infection & amp; Immunity. St. Louis: Mosby, 1996: 1088.

21. Whitcup SM. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy. JAMA . 2000; 283: 653-7.

22. Dolin R, Masur H, Saag MS. AIDS therapy. Philadelphia: Churchill Livingstone, 1999.

24. O'Sullivan CE, Drew WL, McMullen DJ, Miner R, Lee JY, Kaslow RA, et al. Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy. J Infect Dis . 1999; 180: 847-9.

25. Brosgart CL, Louis TA, Hillman DW, Craig CP, Alston B, Fisher E, et al. A randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of cytomegalovirus disease in HIV-infected individuals. AIDS . 1998; 12: 269-77.

26. Mandell GL, Douglas RG, Bennett JE. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 5th ed. Philadelphia: Churchill Livingstone, 2000.

Like this: